Non-invasive Forehead Skin Temperature in Cardiac Surgery
NCT ID: NCT04160845
Last Updated: 2020-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
33 participants
OBSERVATIONAL
2020-09-02
2020-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlation, Accuracy, Precision and Practicability of Zero Heat Flux Temperature Monitoring
NCT02031159
Perioperative Normothermia: Temperature and Prewarming Methods
NCT04011462
Study on Optimal Temperature During Cardiopulmonary Bypass (THERMIC-4)
NCT05996120
Measurement of Core Temperatures During Therapeutic Hypothermia
NCT01292148
Targeted Hypothermia During Cardiac Surgery
NCT01894724
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
anesthesia induction and maintenance use standard systemic anesthesia protocols using propofol-remifentanil-rocurium. Even before inducing anesthesia, it will start monitoring ECGs, noninvasive blood pigmentation, local cerebral oxygen saturation, blood pressure and heart rate.
After anesthesia induction and intraperitoneal intubation, the Temp-NP Hardness Ultrasound and Cardiac Output Monitoring through pulmonary artery catheter are initiated.
Before and after cardiopulmonary bypass, adjust the respiration rate of FiO2 04-0.5 so that the end tidal CO2 is 35-40 mmHg. Apply a positive end-expiratory pressure of 8 mmHg at the end of the period.
For surgery, heparin 3 mg/kg is administered, cardiopulmonary system is operated at medium-low body temperature, cardiopulmonary system is administered, and heart surgery is initiated from a cardiac standstill state. After the heart valve and coronary artery transplantation period, warm up to raise body temperature.
After recovering proper cardiac function, heparin is neutralized by administering 3 mg/kg of protamine and weaning from the cardiopulmonary bypass by administering inotropic agents.
After the anesthesia is finished, the patient is transferred to the intensive care unit in an intubated state, and is kept in isolation with dexmedetomidine until the tube is released.
The temperature monitoring of the sorcery starts the Temp-ZHF monitoring even before the anesthetic induction, and then the Temp-NP and Temp-PAC monitoring after the induction. Temp-NP monitoring devices are removed after surgery, but Temp-ZHF and Temp-PAC monitoring are also maintained in intensive care units after surgery.
The objectives of the study are as follows. primary goal Temp-ZHF vs. Temp-NP 30 minutes after cardiopulmonary bypass. secondary goal
1. After 30 minutes of anesthesia flow, there is a comparison between Temp-ZHF and Temp-NP.
2. It is compared to Temp-ZHF and Temp-PAC after 30 minutes of anesthesia.
3. Compared to Temp-ZHF and Temp-NP 30 minutes after cardiopulmonary bypass.
4. Compared to Temp-ZHF and Temp-PAC 30 minutes after cardiopulmonary bypass
5. 30 minutes after surgery, compared to Temp-ZHF and Temp-PAC.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cardiac surgery
cardiac surgery with hypothermic cardiopulmonary bypass
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2\. Patients Signed to Participate in Research
Exclusion Criteria
* 2\. Under 19 Criteria for exclusion during research
1. In case a patient who decides to participate in a study refuses to make a decision or reverses (rejects) a decision after participation
2. Patients who fail to perform Temp-NP surveillance during heart surgery
3. Deep hypothermia patients
4. Continuing the study is detrimental to the welfare of the study subjects
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Konkuk University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tae-Yop Kim, MD PhD
Professor Anesthesiology
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-11-008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.